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Abstract
We have investigated molecular mechanisms for muscle mass accretion in a non-inbred mouse model (DU6P mice)
characterized by extreme muscle mass. This extreme muscle mass was developed during 138 generations of phenotype
selection for high protein content. Due to the repeated trait selection a complex setting of different mechanisms was
expected to be enriched during the selection experiment. In muscle from 29-week female DU6P mice we have identified
robust increases of protein kinase B activation (AKT, Ser-473, up to 2-fold) if compared to 11- and 54-week DU6P mice or
controls. While a number of accepted effectors of AKT activation, including IGF-I, IGF-II, insulin/IGF-receptor, myostatin or
integrin-linked kinase (ILK), were not correlated with this increase, phosphatase and tensin homologue deleted on
chromosome 10 (PTEN) was down-regulated in 29-week female DU6P mice. In addition, higher levels of PTEN
phosphorylation were found identifying a second mechanism of PTEN inhibition. Inhibition of PTEN and activation of AKT
correlated with specific activation of p70S6 kinase and ribosomal protein S6, reduced phosphorylation of eukaryotic
initiation factor 2a (eIF2a) and higher rates of protein synthesis in 29-week female DU6P mice. On the other hand, AKT
activation also translated into specific inactivation of glycogen synthase kinase 3ß (GSK3ß) and an increase of muscular
glycogen. In muscles from 29-week female DU6P mice a significant increase of protein/DNA was identified, which was not
due to a reduction of protein breakdown or to specific increases of translation initiation. Instead our data support the
conclusion that a higher rate of protein translation is contributing to the higher muscle mass in mid-aged female DU6P
mice. Our results further reveal coevolution of high protein and high glycogen content during the selection experiment and
identify PTEN as gate keeper for muscle mass in mid-aged female DU6P mice.
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Introduction
Critical Role of AKT for Muscle Accretion
AKT represents the key factor of muscle accretion and
maintenance [1,2]. AKT 1 and AKT 2 double knockout mice
were characterized by severe growth retardation, reduced muscle
mass, particularly due to smaller muscle fiber volumes and
perinatal lethality [3]. On the other hand, overexpression of AKT
in transgenic mice resulted in muscle fiber hypertrophy [4] and
higher muscle strength [5]. Interestingly, knockdown of AKT 1 in
cell culture studies completely prevented myoblast differentiation
but had no effect on cell proliferation and it was concluded that
AKT 1 is particularly relevant for muscle formation in embryonic
development [6,7].
Control of AKT
The activity of AKT 1 is controlled by phosphorylation of
threonine residue 308 and serine residue 473 [8]. While Thr-308 is
phosphorylated by phosphoinositide dependent kinase 1 (PDK1)
as part of the PI3 pathway [9], Ser-473 can be activated by
different kinases. It has been demonstrated, that mammalian
target of rapamycin (mTOR) in complex 2 (TORC2; [10]) or
integrin-linked kinase (ILK) [11] can phosphorylate Ser-473
present in AKT 1. Furthermore, it was suggested that TGFß1
affects Ser-473 phosphorylation of AKT 1 via upregulation of ILK
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39711[12]. TGFß has recently also been shown to block gene expression
of IGF-II in myoblasts [13] suggesting different levels of
interaction for TGFß and muscle differentiation. Interestingly,
within the cell activation of Ser-473 AKT has inversely been
correlated with expression of PTEN [14]. PTEN, which primarily
is recognized as a tumor suppressor, acts by dephosphorylating
PIP3 and thereby prevents activation of PDK1 on the one hand
and recruitment of AKT to the plasma membrane on the other
[15].
Prominent functions for muscle growth and control of AKT
have been attributed particularly to IGF-I, IGF-II and to growth
differentiation factor-8 (myostatin). The latter is mutated in
extreme muscle phenotypes as found in Belgian Blue or
Piedmontese cattles [16].
Effects of AKT
Activated AKT affects protein metabolism via at least two
independent mechanisms: First, AKT can activate ribosomal
protein S6 via mTOR and p70 ribosomal protein S6 kinase
(p70S6K). Secondly, AKT also affects protein translation through
phosphorylation of GSK3ß [17,18]. AKT also exerts affects on
glucose metabolism and controls GLUT4 dependent glucose
uptake [19,20] and glycogen synthesis via GSK3ß and glycogen
synthase [21,22].
Models to Study Control of Protein Accretion
Functional genome analysis by the employment of a number of
loss or gain of function models in vitro and in vivo have attributed
specific functions of isolated growth factors or receptors for the
accretion and maintenance of muscle mass [23,24]. However the
limitations of such reverse genetics are due to the fact, that isolated
gene effects do not merge genetic complexity present in real life. In
addition, transgenic or knockout models do not contain reliable
information on the physiological relevance of a derived hypothesis.
Thus we used a mouse model established by means of classical
genetics [25,26] and asked, which from the different mechanisms
show up with the phenotype of high protein mass. Since the
establishment of our model was originally based on an outbred
genetic background, we presume the presence of multiple
mechanisms attributing to the robust phenotype. In spite of 138
generations of phenotype selection we identified the presence of
one specific mechanism potentially affecting activity of AKT
arguing against outmost biodiversity as a mechanism of higher
protein accretion in our system. In addition, our experiment
argues in favor of an intricate relationship between protein and
glycogen metabolism in muscle tissue.
Materials and Methods
Animals
All procedures were done in accordance to national and
international guidelines and approved by our own institutional
board (Animal Protection Board from the Leibniz-Institute for
Farm Animal Biology) and by the national Animal Protection
Board Mecklenburg-Vorpommern (file number: LALLF M-V/
TSD/7221.3-1.2-037/06). We used a non inbred mouse line
(DU6P) established by phenotype selection over 138 generations
for high protein mass at an age of 42 d after birth [27,28]. In
addition, an unselected control mouse line Fzt:DU (generation
142) was used. The initial population was derived from an original
crossbred of four outbred (NMRI orig., Han:NMRI, CFW, CF1)
and four inbred (CBA/Bln, AB/Bln, C57BL/Bln, XVII/Bln)
populations. In brief, during the whole selection experiment for
every generation 60–80 breeds were established. In order to
maintain maximal genetic complexity all breeds had small inbred
coefficients as calculated by an in house computer program. From
every litter two male mice were randomly selected and analyzed
for the total protein amount of the carcass (without skin, head and
all inner organs). Only littermates from mice characterized by the
highest protein amounts were selected for the next round of
selection. The selection intensity as a function of litter quality
varied between 50% and 70%. The mice were maintained in
a semi-barrier system and had free access to a standard diet
(breeding diet 1314, Altromin, Lage, Germany) and water ad
libitum.
Longitudinal Study Design and Sampling Regime
A longitudinal study was performed by dissecting male and
female mice (n=15) at 8 time points (2, 4, 7, 11, 16, 29, 42, 54
weeks). The body weights were documented in monthly intervals
and at dissection. In addition, at dissection weights of carcass and
Musculus quadriceps femoris were recorded, the latter was stored at
280uC until analysis. The carcass represents the body with
muscles and bones after removal of the skin and inner organs.
Western Immunoblot Analysis
Musculus quadriceps femoris was homogenized in lysis buffer
(#9803, New England Biolabs, Frankfurt, Germany) supplemen-
ted with protease inhibitor cocktail (Complete Mini, Roche,
Mannheim, Germany) using the Precellys24 (Peqlab Biotechnolo-
gie GmbH, Erlangen, Germany). After centrifugation (10000 g,
2 min, 4uC) and elimination of cell debris, protein content of the
whole tissue lysate was quantified using the bicinchoninic acid
method as described previously [29].
Twenty micrograms of protein from the pool samples were
separated on 12% SDS-PAGE gels and transferred to polyviny-
lidene fluoride membranes (Millipore, Eschborn, Germany). Equal
loading of the gels and proper transfer of the proteins to the
membranes were verified by Coomassie Blue staining. Membranes
were blocked in 5% dry milk and 1% Tween20 dissolved in Tris
buffered saline/TBST. After three washings in TBST buffer the
membranes were incubated with primary antibodies for 1.5 hours
at room temperature. We analyzed protein expression and
phosphorylation by using a set of different antibodies (see table 1).
All antibodies were purchased from Cell Signaling Technology
(New England Biolabs, Frankfurt, or St. Cruz, Heidelberg,
Germany) and have been used according to the manufacturer’s
instructions.
After three washings in TBST the membranes were incubated
with horseradish peroxidase coupled goat anti-rabbit IgG (1:2000,
#7074) or horse anti-mouse IgG (1:5000, #7076) for 1 h at room
temperature. Finally, membranes were developed on a Kodak
Image Station 4000 MM (Stuttgart, Germany) using an enhanced
chemiluminescence detection kit (ECL Advance Western Blotting
Detection Kit; GE Healthcare, Freiburg, Germany). Band in-
tensities were quantified using the ImageQuant Software package
(GE Healthcare). To estimate the specific activation for distinct
signaling molecules, signals from phospho-specific antibodies were
normalized for total protein expression (phospho/total protein, see
table 1). Therefore, membranes were initially incubated with
phospho-specific antibodies. The same membrane was then
reprobed by using antibodies directed against the total protein.
Results are presented in percent of phospho/total protein or total
protein/loading control.
Isolation of the Membrane Fraction
Plasma membranes were prepared as described previously [30].
Muscle tissue were homogenized 2 times for 54 sec in TRIS buffer
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Mini, Roche, Mannheim, Germany) using the gentleMACS
TM
dissociator system (Mylteni Biotec GmbH, Bergisch-Gladbach,
Germany). Cell debris and nuclei were separated by centrifugation
(10000 g, 10 min, 4uC). The supernatant containing plasma
membranes and the cytosolic fraction was separated in a final
centrifugation step for 30 min at 17530 g and 4uC. The efficient
removal of cytosolic proteins in isolated plasma membranes was
demonstrated by the absence of cytosolic GAPDH (data not
shown).
Analysis of Muscle Glycogen
Glycogen content was quantified in muscle samples of 29-week
female Fzt:DU (n=6) and DU6P mice (n=12) using the Starch kit
(#10207748035, charge number 11849700, Boehringer Man-
nheim/R-Biopharm, Germany) according to the manufacturers
instructions. Furthermore, muscle glycogen was also visualized by
histochemistry. Serial transverse sections (5 mm) were cut from
muscle samples of 29-week female Fzt:DU and DU6P mice with
a MEV cryostat (SLEE Technical GmbH, Mainz, Germany) at
220uC and mounted on slides. Glycogen was detected by
performing the Perdiodic Acid Schiff (PAS) staining. Sections
were affixed by 5 min incubation in methanol/acetone 1:1 at
220uC and washed for 5 min with double distilled water. The
slides were incubated for 5 min with freshly prepared 1% periodic
acid (Carl Roth GmbH + Co. KG, Karlsruhe, Germany). After
a 5 min washing step with aqua dest., the slides were incubated in
Schiff reagent (Merck, Darmstadt, Germany) for 10 min. The
slides were then washed in tap water (,35uC), counterstained with
Mayer’s hematoxylin (Merck, Darmstadt, Germany) for 30 sec
and washed again with tap water for 5 min. Finally, the slides were
mounted with Aquatex (Merck, Darmstadt, Germany) and muscle
glycogen was visualized by light microscopy (Nikon, Eclipse E600,
Lucia G software).
Measurement of Serum IGF-I and IGF-II
Total IGF-I in serum of female mice (n=8) was measured in
triplicates with a commercially available ELISA as per manufac-
turer’s instructions (mouse IGF-I assay #E25, Mediagnost,
Reutlingen, Germany). Circulating IGF-II concentrations in
Fzt:DU and DU6P mice (n=10) have been measured by RIA
as described before [31].
Quantification of Muscle RNA and DNA Contents
To isolate RNA of Musculus quadriceps femoris (n=5), a defined
amount of pestled tissue was homogenized with TRIreagent
Table 1. Antibodies used in the study.
Phospho-specific antibodies Source Order number # Company
AKT-Ser473 rabbit 9271 Cell Signaling
AKT-Thr308 rabbit 9275 Cell Signaling
GSK3ß-Ser9 rabbit 9336 Cell Signaling
PTEN-Ser380 rabbit 9551 Cell Signaling
p44/42 MAPK-Thr202/204 rabbit 4370 Cell Signaling
p38 MAPK-Thr180/182 rabbit 9211 and 4511 Cell Signaling
PDK1-Ser241 rabbit 3061 Cell Signaling
eIF2a-Ser51 rabbit 3398 Cell Signaling
IGF-IRß/Insulin-Rß-Tyr1135/1136-1150/1151 rabbit 3024 Cell Signaling
S6 Ribosomal Protein-Ser235/236 rabbit 4858 Cell Signaling
p70S6 Kinase-Thr389 rabbit 9234 Cell Signaling
Phospho-unspecific antibodies Source Order number # Company
AKT rabbit 9272 Cell Signaling
GSK3ß rabbit 9315 Cell Signaling
PTEN rabbit 9552 and 9188 Cell Signaling
p44/42 MAPK rabbit 4695 Cell Signaling
p38 MAPK rabbit 9212 Cell Signaling
PDK1 rabbit 3062 Cell Signaling
eIF2a mouse 2103 Cell Signaling
IGF-IRß rabbit 3018 Cell Signaling
S6 Ribosomal Protein rabbit 2217 Cell Signaling
p70S6 Kinase rabbit 2708 Cell Signaling
ILK rabbit 3856 Cell Signaling
a-Tubulin rabbit 2125 Cell Signaling
Ubiquitin mouse 3963 Cell Signaling
GDF-8 rabbit sc-6885 Santa Cruz
IGF-II mouse sc-74119 Santa Cruz
doi:10.1371/journal.pone.0039711.t001
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temperature (RT). After centrifugation for 10 min at 12000 g
supernatants were vortexed in 100 ml Chloroform, incubated for
further 10 min at RT and centrifuged (12000 g, 10 min). The
isolated liquid phase was mixed with 500 ml isopropanol and after
5 min (RT) another centrifugation step at 12000 g for 8 min was
performed. The achieved pellet was washed with 75% ethanol,
centrifuged (7500 g, 5 min), air-dried and resolved in 50 ml sterile
water.
DNA of a defined amount of Musculus quadriceps femoris was
isolated with the High Pure PCR Template Preparation Kit
according to manufacturer’s instructions (Roche, Mannheim,
Germany). RNA and DNA contents were analysed by using the
Nanodrop ND-1000 spectrophotometer (Peqlab Biotechnologie
GmbH, Erlangen, Germany).
Analysis of Translational Activity
Flash frozen mouse muscle tissue was lysed mechanically in
polysome buffer (300 mM KCl, 5 mM MgCl2, 10 mM PIPES
pH 7.4), 0.5% NP40, 27.8 mg/ml Heparin-Sodium (Ratiopharm,
Ulm, Germany) and 100 ng/ml Cycloheximide (Sigma, Munich,
Germany) with Tissue Lyser LT (Qiagen, Hilden, Germany). To
separate polysomal RNA from non-polysomal RNA, linear sucrose
gradients were built from polysome buffer with 0% to 50% sucrose
concentration [32]. Stability of linear gradients was confirmed by
a refractometer (Type MHRB 90, Mu ¨ller, Erfurt, Germany).
Muscle lysate was cooled on ice and layered onto gradients which
were subjected to centrifugation at 28000 g in a SW40 rotor
(Beckmann Optima
TM L Preparative Ultracentrifuge, Krefeld,
Germany) at 4uC for 120 min. 13 fractions of 1 ml were collected
from the top of the gradient and the ratio of 18S and 28S rRNA
was measured to obtain the polysome profile on Agilent 2100
Bioanalyzer (Waldbronn, Germany). Based on the 28S/18S Ratio,
fractions 5 to 6 (from top of gradient) were described as non-
polysomal (ratio ? 2) and fractions 9 to 11 as polysomal (ratio , 2)
[33]. By normalizing the RNA yields on fraction number 5,
polysome profiles of different samples could be compared to each
other. The addition of RNA yields from fractions 5 to 6 and 9 to
11 gave a hint on total RNA amount in gradients.
Analysis of Amino Acid Metabolism
Free amino acids were analyzed by HPLC as described
previously [34]. In brief, 10-fold diluted samples were derivatized
using ortho-phthaldialdehyde/3-mercaptopropionic acid for pri-
mary and 9-fluorenylmethoxycarbonyl chloride for secondary
amino acids [35]. Chromatographic separation was performed on
a 25064 Hyperclone ODS column protected by a precolumn
(Phenomenex, Aschaffenburg, Germany). The gradient system
consisted of 40 mM phosphate buffer (pH 7.8) and increasing
amounts (6–100%) of a mixture containing acetonitril/methanol/
water (45/45/10). Fluorimetric detection of primary and second-
ary amino acid derivatives was performed at 340/450 (excitation/
emission) and 266/305 nm, respectively. Dilution curves from
supplemented standard mixtures of amino acids (A9906 Sigma,
Munich, Germany) were used in order to assign retention times
and to obtain quantitative results.
Data Analysis and Statistics
The statistical analysis was performed using the one-way
analysis of variance from the JMP 8 software. The graphs were
illustrated by using graph pad prism (Graph pad Software, La
Jolla, USA). Weight data were analyzed by using the student’s t-
test. The activation of the different signaling proteins is shown as
relative activation (phospho-specific/total). Female samples were
normalized for 11-week control mice. They were set to 100% and
the results of the DU6P mice are shown as percentage. Some data
are presented as percentage of control, which indicated the part of
the same age Fzt:DU control. The significance level was set at
p,0.05. Data are presented as mean 6 SEM. The ratio protein/
DNA was statistically evaluated with the Wilcoxon-signed rank test
with the help of the SAS program.
Results
Success of Phenotype Selection and Weight Parameters
Long-term phenotype selection in DU6P mice for high protein
mass resulted in a considerable selection success during the
experiment. At the beginning of the selection period the protein
content of 42 day old male mice amounted to 3.4 g. After 138
generations of selection for high protein mass the protein content
increased to 7.8 g (p,0.001; Figure 1 A and B). Selection for high
protein content also affected the absolute body mass in female
DU6P mice if compared to the respective control mice in all age
groups measured between week 2 and 54 after birth. Absolute
weights of isolated muscles (M. quadriceps femoris, muscles are
illustrated in Figure 1 C) in female DU6P mice were significantly
higher (p,0.05) in all age groups studied if compared to Fzt:DU
mice, respectively. Depending on age DU6P mice were charac-
terized by up to 2-fold higher body weights compared to their
controls (p,0.001; Figure 1 D). If corrected for body weights and
calculated as relative muscle weights, muscle wet masses were
higher in all age groups (Figure 1 E; p,0.03) demonstrating
particular growth effects in muscles from DU6P mice in response
to trait selection. Pronounced growth effects were not restricted to
M. quadriceps femoris but seemed to be present also in other muscle
tissues since the relative carcass weights from DU6P mice
compared to controls were significantly increased if compared to
controls (p,0.0001; Figure 1 F). Relative liver weights were
similar, while relative brain weights were reduced in female DU6P
mice and controls (p,0.001, data not shown). The effects of
phenotype selection on weight parameters were similar in males
and in females (data not shown).
Serum Levels of IGF-I and IGF-II
Female DU6P mice had significantly higher IGF-I serum levels
in all groups studied from 4 to 54 weeks of age if compared to
Fzt:DU mice (p,0.05). In contrast, 2-week DU6P female mice
exhibited lower IGF-I serum levels (p=0.0153, Figure 2 A).
Serum IGF-II levels were unaffected by age or phenotype in 11, 29
and 54-week female mice (not shown).
Muscle Precursor IGF-II
In muscles from female DU6P mice the precursor of IGF-II was
detected in significantly increased amounts compared to Fzt:DU
(11 weeks: 206% of control, 29 weeks: 292% of control, 54 weeks:
585% of control; all p,0.0001; Figure 2 B).
Analysis of Signal Transduction
To get an overview on longitudinal activation of signaling
pathways, we have performed an initial pool analysis (n=15) in
different age groups between 2 and 54 weeks and both sexes (2, 4,
7, 11, 16, 29. 42 and 54 weeks; data not shown). In the pool
samples from female DU6P mice, activation of AKT on Ser-473
was strongly increased at an age of 16 (Fzt:DU: 54%; DU6P:
414%) and 29 weeks (Fzt:DU: 11%; DU6P: 510%). Although on
a lower level, in males an increase was also detected in 16 (Fzt:DU:
75%; DU6P: 249%) and 29-week DU6P mice (Fzt:DU: 114%,
DU6P: 162%). No consistent pattern of PDK1 activation could be
PTEN as an Effector of Muscle Mass
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patterns of p44/42 and p38 MAPK activation were similar in
DU6P and Fzt:DU mice in both sexes, respectively. If compared
to females, male DU6P and Fzt:DU mice displayed higher levels of
p38 or p44/42 MAPK activation particularly at the age of 29
weeks. As a result of our screening protocol for the activation of
central signalling cascades in the longitudinal approach we
considered activation of AKT in adult female mice as the most
significant finding for further analysis. The expression and
activation of AKT was studied also in unpooled samples (n=9)
from 11-, 29- and 54-week female mice of both lines. In fact,
specific activation of AKT at Ser-473 was higher in 29-week mice
if compared to 11-week mice (p=0.0199) of the same phenotype
and to 29-week control mice (p,0.0001; Figure 3). Activation of
AKT at Thr-308 could not be detected in whole cell lysates but
only as faint bands present in the isolated plasma membrane
fraction (data not shown).
Mechanisms of AKT Activation in Muscle
In order to identify mechanisms responsible for altered
activation at Ser-473 we have studied known effectors of AKT
in female mice (Figure 4). IGF-1Rß expression and phosphoryla-
tion was detected in purified plasma membranes from muscle
tissues (Figure 4 A). However no significant differences could be
measured for the activation of IGF-1Rß in the different age and
genetic groups studied from female mice. ILK expression was
almost undetectable in tissue extracts of 29-week female DU6P
mice (18% of control, p,0.0001; Figure 4 B) if compared to
females of 11 and 54 weeks of age. In addition, ILK localization in
the cytoplasmic membrane fraction was significantly reduced in
Figure 1. Long-term phenotype selection for high protein mass in mice. A: Phenotypes of female Fzt:DU and DU6P mice at the age of 11, 29
and 42 weeks. B: Success for the selected trait (protein mass) in the course of long-term selection in DU6P mice versus unselected control mice
(Fzt:DU). C: Dissected M. quadriceps femoris of 11, 29 and 42-week female Fzt:DU and DU6P mice. D: Longitudinal body weights in female DU6P mice
versus Fzt:DU mice. E and F: Relative weights of M. quadriceps femoris and carcasses from female Fzt:DU and DU6P mice (n=15; p,0.03 for all
comparisons of age-matched mouse lines). The sample number (n) depicts the number of samples per age group, the error bars represent SEM.
doi:10.1371/journal.pone.0039711.g001
PTEN as an Effector of Muscle Mass
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e3971154-week female DU6P mice if compared to 11-week DU6P mice,
while in control mice no difference was detectable (data not
shown). Next, also expression of myostatin (GDF-8), as an
important inhibitor of muscle accretion, was investigated. How-
ever, in 29-week female DU6P mice higher expression of the
active 26 kDa peptide of myostatin was detected if compared to all
Figure 2. A: Serum IGF-I levels in female Fzt:DU and DU6P mice over life time (n=8 per age group). B: Expression of IGF-II precursor
(23 kDa) in muscle tissues from 11-, 29- and 54-week female Fzt:DU and DU6P mice (n=10 per age group). The results are normalized for the signal
intensities as detected by Coomassie blue staining of the membranes used for Western immuno detection. Data are expressed as percent of female
11-week Fzt:DU mice (100%). The error bars represent SEM.
doi:10.1371/journal.pone.0039711.g002
Figure 3. Analysis of signal transduction in muscle lysates from 11-, 29- and 54-week female DU6P and Fzt:DU mice. The Western blot
inserts show phosphorylated (Ser-473) and total expression of AKT from one representative experiment, whereby all samples were studied on the
identical membrane. Each Western blots were performed three times. Thus a total of 9 different animals was included in the bar chart for each
timepoint. Specific activation was calculated from the ratios of phosphorylated versus total AKT (n=9 per age group). Coomassie blue staining of the
membranes used for Western immuno detection was used as loading control. The error bars represent SEM.
doi:10.1371/journal.pone.0039711.g003
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respectively (Figure 4 C).
Activation of AKT at Ser-473 is inhibited by phosphatase
PTEN, which was strongly decreased in 29-week female DU6P
mice (Figure 4 D). Although expression of total PTEN was severely
reduced, we were able to identify increased levels of PTEN
phosphorylation in 29-week female DU6P mice if compared to 11-
week DU6P mice.
Analysis of AKT Substrates
AKT controls growth and metabolism by phosphorylation of
several enzymes (Figure 5). Phosphorylation of GSK3ß as
a direct target of AKT was more than 2-fold (p,0.05) increased
in 29-week female mice if compared to 11- and 54-week mice.
In addition, reduced (p,0.05) levels of eIF2a phosphorylation
in 29-week female DU6P mice were detected if compared to
11-week DU6P mice and 29-week control mice. Expression of
total p70S6 kinase was down regulated in 29-week DU6P
female mice when compared to all other age groups studied in
DU6P and Fzt:DU (p,0.05). In spite of very low total p70S6
kinase expression, phosphorylated p70S6K could be detected in
muscles from 29-week female DU6P mice. If normalized for the
low expression levels specific activation of p70S6K was
significantly higher if compared to 11- and 54-week female
DU6P mice (p,0.05). We also studied activation of the S6
ribosomal protein. In 29-week female DU6P mice we identified
Figure 4. Analysis of signal transduction in muscle lysates from 11, 29 and 54-week female DU6P and Fzt:DU mice. Western blot
identified phosphorylated and total expression of the respective signaling molecule. Specific activation was calculated from the ratios of
phosphorylated versus total protein. Coomassie blue staining of the membranes used for Western immuno detection was used as loading control. A:
IGF-1Rß in membrane fractions (n=3); B: ILK (n=9); C: GDF-8, 26 kDa band (n=11) and D: PTEN (n=9). The inserts provide representative
experiments, whereby all samples were studied on the identical membrane. Sample numbers (n) depict the number of samples per age group, the
error bars represent SEM.
doi:10.1371/journal.pone.0039711.g004
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(p,0.05).
Immunhistochemical and Biochemical Analysis of
Glycogen in Muscle Tissue
Robust inactivation of GSK3ß was correlated with 3-fold
increased levels of muscle glycogen in 29-week female DU6P mice
if compared to Fzt:DU (Fzt:DU: 0.0460.01%; DU6P:
0.1260.02%; p=0.0079; Figure 6). This observation was
confirmed by histochemistry.
Protein Synthesis Versus Protein Breakdown
The acquisition of muscle mass can further be achieved by
higher protein synthesis and/or by a reduction of protein
breakdown. We thus have analyzed activity of the ubiquitin/
proteasome pathway by looking at global patterns of protein
ubiquitination. In female 11- and 29-week DU6P mice higher
levels of ubiquitinated proteins were detected when compared to
age-matched Fzt:DU mice (p,0.05, Figure 7 A). In serum from
female DU6P mice concentrations of 1/3-methyl-histidine as
a marker of protein degradation and ornithine as a key molecule
of the urea-cycle, were elevated if compared to controls (p,0.05,
Figure 7 B and C). As a second marker of protein degradation also
a-aminoadipic acid was significantly higher in 29-week DU6P
mice compared to the controls (data not shown). While excluding
reduced breakdown as a mechanism of muscle mass acquisition in
DU6P mice we investigated the control of protein synthesis in
DU6P mice and controls (table 2). Notably, female 29-week
DU6P mice had a higher protein/DNA ratio when compared to
age-matched controls as shown by the Wilcoxon-signed-rank test
(Spearmen’s rank correlation coefficient is not significantly
different from 0, i.e. both control groups are significantly different
Figure 5. Analysis of signal transduction in muscle lysates from 11, 29 and 54-week female DU6P and Fzt:DU mice. Western blot
identified phosphorylated and total expression of the respective signaling molecule. Specific activation was calculated from the ratios of
phosphorylated versus total protein. A: GSK3ß (n=9); B: eIF2a (n=9); C: p70S6 kinase (n=3); D: ribosomal protein S6 (n=6). The inserts provide
representative experiments, whereby all samples were studied on the identical membrane. Sample numbers (n) depict the number of samples per
age group,the error bars represent SEM (n.c.: not calculated due to low signal intensity).
doi:10.1371/journal.pone.0039711.g005
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all groups, we thus investigated if translational initiation was
specifically affected and studied the relative distribution of mRNA
present in polysomal versus non-polysomal fractions. While the
relative distribution of free versus polysomally bound mRNA
transcripts were similar in both genetic groups (table 2), not
arguing for higher translation initiation, total amount of mRNA
transcripts bound in polysomal complexes was significantly
increased in 29-week female DU6P mice when compared to
Fzt:DU mice (p,0.05).
Discussion
A New Mouse Model to Study Complex Control of
Muscle Accretion
We have used a novel mouse model characterized by extreme
muscle accretion and maintenance throughout lifetime. The
mouse model has been developed by repeated phenotype selection
for high protein content in 42 day old male mice. The selection
experiment was performed for 138 generations, corresponding to
a time span of more than 35 years and has been described in detail
before [26,36]. Since the selection experiment has been performed
on an outbred background (60–80 breeding pairs per cycle) it can
be assumed that a complex setting of alleles is contributing to the
marked phenotype expressed by DU6P mice. Furthermore, we
have to assume multiple mechanisms, positively affecting muscle
accretion, have been emerged during the selection experiment.
Our model represents an important tool of functional genome
analysis and for estimating the physiological relevance of gene
functions identified by transgenic or knockout models. An inherent
feature of non-inbred models in part is extremely high phenotype
variation. For selected parameters high phenotype variability was
also found in the present study. As described in Materials and
Methods, the phenotype of extreme protein accretion was
established by crossbreeding 60–80 pairs in parallel during the
complete selection experiment by keeping inbred coefficients as
small as possible. Thus higher genetic complexity may be
responsible for a higher phenotype variance also in DU6P mice.
While high phenotype variability due to higher genetic complexity
may complicate physiological studies, it basically can be consid-
ered also as a strength of the model, which represents not only
a restricted genetic background. Thereby, phenotype based
models add positive value to known gene functions by informing
about their respective physiological relevance. Thus, our model is
of central interest for general physiology, since it reveals strategies
for the accretion and maintenance of muscle mass as invented and
applied during evolution.
Analysis of Signal Transduction from Weaning to
Adulthood
To study mechanisms of muscle accretion and maintenance we
monitored longitudinal activation of intracellular signaling cas-
cades in female mice. According to current concepts AKT
represents a central effector of muscle growth [37]. Therefore,
we have screened pooled muscle lysates from 8 different age
groups in the postnatal period between 2 and 54 weeks of age for
the activation of AKT on Ser-473. Clearly, the profiles of AKT
activation were different in mice selected for high protein accretion
and randomly selected in mice. In adult female DU6P mice,
extreme muscle mass coincided with massive increases of AKT
activation in 16- and 29-week mice if compared to older or
younger mice. The strong increase of AKT activation in 29-week
female DU6P mice was confirmed on the level of single sample
analysis. The reason for the absence of a stronger AKT activation,
particularly in pubertal mice, characterized by higher growth
rates, is unclear but was not expected. Ser-473 phosphorylation of
AKT is thought to depend particularly on mTOR, present in
complex 2 [38,39]. Since mTOR phosphorylation was compara-
bly low in 29-week female DU6P mice (Ser-2448), control of
mTOR activity is not a plausible mechanism for the acute
activation of AKT (data not shown). It has further been mentioned
that full activation of AKT is dependent on Thr-308 phosphor-
ylation by PDK1 [40]. However, the levels of phosphorylated
AKT at Thr-308 were on very low levels suggesting that there is
no robust impact of PDK1 via AKT in our model. In addition,
activation of PDK1 itself was not affected in DU6P mice if
compared to controls (data not shown). Abundance and
phosphorylation of muscular IGF-I receptors were also found on
very low levels arguing against acute regulation by growth factors
via the IGF-I receptor/PDK1/AKT axis on muscle maintenance
in adult female mice [41]. Although IGF-I serum levels were
higher in adult female DU6P mice if compared to controls, acute
regulation between 11- and 29-week female DU6P mice was
absent and therefore not correlated with the acute activation of
AKT. Interestingly, local IGF-II expression also ranged on higher
levels in DU6P mice if compared to control mice. In pigs a QTL
was mapped to the IGF2 gene locus on chromosome 2 with
a strong effect on lean mass in fact supporting functional relevance
of IGF-II for muscle mass [42]. However, IGF-II expression in our
mouse model cannot directly be used as a potential explanation for
the acute activation of AKT in 29-week female mice, since the
levels of serum IGF-II were similar in 11- and 29-week female
DU6P mice. Nevertheless we cannot exclude conditional effects of
local IGF-II in 29-week female mice particularly in a context of
PTEN (see further down).
As one of the prominent inhibitors of muscle accretion,
myostatin has been identified in mice [43,44] and cattle [45,46].
Figure 6. Higher levels of muscle glycogen in 29-week female
DU6P mice. Top: Biochemical analysis of glycogen content in muscle
tissue of 29-week female Fzt:DU (n=6) and DU6P (n=12) mice. Lower:
PAS staining of cryosectioned muscle of 29-week Fzt:DU and DU6P
female mice. The images correspond to an area of about 1.360.88 mm
in the histological sections. The error bars represent SEM.
doi:10.1371/journal.pone.0039711.g006
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acts on AKT phosphorylation [47]. However, myostatin expres-
sion was strongly increased in 29-week female DU6P mice, which
did not explain the robust phenotype of protein accretion in adult
female DU6P mice.
Recent evidence has been provided for the control of AKT
activity by integrins [48]. Particularly, ILK has been demonstrated
to have a strong effect on Ser-473 phosphorylation of AKT [49].
However, ILK was severely downregulated between week 11 and
week 29 of age and thus almost undetectable in muscular tissue
extracts from 29-week female DU6P mice. Since ILK is recruited
to the plasma surface in the course of AKT activation, we have
isolated a plasma membrane fraction from muscles of both genetic
groups. In fact we were able to detect higher amounts of ILK
bound to the cytoplasmic membrane if compared to whole tissue
extracts, however again with reduced levels in 29-week female
DU6P mice, which thus also was not explaining the increased
levels of phosphorylated Ser-473-AKT.
As the exclusive motive for the strong increases of Ser-473-AKT
phosphorylation, protein levels of PTEN were found to drop
severely in 29-week female DU6P mice between 11 and 54 weeks
of age. PTEN as a phosphatase catalyzes dephosphorylation of
PIP3 to PIP2 and blocks activation of AKT [50,51]. In spite of
lower levels of total PTEN expression in muscles from 29-week
female DU6P mice, we detected higher levels of phosphorylated
PTEN, which is a known mechanism of PTEN inactivation
[52,53]. Although it is impossible to judge on the relative impacts
of lower expression versus higher inactivation of PTEN, we have
identified two independent mechanisms of PTEN-dependent
evolved during the long term selection process for the control of
AKT activity exerted on one hand, by down regulation of the
PTEN protein amount and on the other, by inactivation of
remnant PTEN. While Ser-380 of PTEN can be phosphorylated
by casein kinase 2 [54] the control of PTEN expression [55] or
degradation [56] is more complex. In the cytosol, PTEN
expression represents a central regulatory mechanism for the
control of AKT in malignant and non malignant conditions
Figure 7. Analysis of protein metabolism in female DU6P and Fzt:DU mice. A: Western blot of muscle lysates in 11-, 29- and 54-week DU6P
and Fzt:DU mice identified different proteins tagged with Ubiquitin for protein degradation (n=5 per age group). Intensities of the complete lanes
were calculated and normalized for the Coomassie blue signals present in the identical complete lane on the membranes used for Western immuno
detection. The insert provides a representative experiment, whereby all samples were studied on the identical membrane. Serum levels of 1/3-
methyl-histidine (B) and ornithine (C) were analyzed by quantitative HPLC as described in Materials and Methods. The error bars represent SEM.
doi:10.1371/journal.pone.0039711.g007
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sufficient to increase wet weight of the striated muscles (M. tibialis
anterior). Further work is required in order to study the basis of
altered PTEN expression or stability in female DU6P mice. In
future studies also a potential role of local IGF-II for PTEN
expression needs to be concerned since in human breast cancer
cells a feedback loop comprising IGF-II and PTEN has been
described by Perks et al. [60].
Molecular Targets of Phosphorylated AKT in Female
DU6P Mice
AKT represents a central control element for a plethora of
effects on growth and metabolism [61,62]. With respect to muscle
accretion predominantly the AKT/p70S6 kinase/S6 kinase
pathway is thought to be important [63,64]. However, in muscles
from 29-week female DU6P expression of p70S6 kinase surpris-
ingly was almost undetectable and reduced if compared to 29-
week female controls. In spite of severely reduced expression,
phosphorylated p70S6K was found in 29-week female DU6P
mice. In addition, robust and specific activation of S6 kinase was
detected in 29-week female DU6P mice. Furthermore, an almost
2-fold specific activation of GSK3ß was measured in muscles from
29-week female DU6P mice. In an unphosphorylated form
GSK3ß is known to phosphorylate and thereby inhibit glycogen
synthase [65]. Phosphorylation of GSK3ß results in higher
glycogen levels due to the lack of glycogen synthase inhibition.
In fact, intramuscular glycogen levels were about 3-fold increased
in 29-week female DU6P mice when compared to controls. It is
important to note that muscle glycogen also may be due to altered
muscle fiber composition, since glycolytic white muscle fibers
contain more glycogen. However at least after 40 generations of
selection fiber composition was similar in both strains [66].
In addition, the phosphorylation of eIF2a negatively regulates
protein synthesis by inhibiting the ability of eIF2B to properly
exchange GTP for GDP and is known to have a role in growth
control [67,68]. While the patterns of total eIF2 a where similar in
both strains, reduced phosphorylation of eIF2a was exclusively
found in 29-week female DU6P mice. Thus several mechanisms
have evolved in female 29-week DU6P mice in response to growth
selection: S6K, GSK3ß and eIF2a all have known positive effects
on protein synthesis. Higher amounts of DNA in DU6P mice are
in line with higher numbers of cell nuclei in individual muscle
fibers (increases by up to 39%) and increases of fiber cross sections
Table 2. Analysis of body weight, contents of DNA, RNA and protein in M. quadriceps femoris of Fzt:DU (29 weeks) and DU6P (11
and 29 weeks) female mice (n=5).
DU6P 11 weeks DU6P 29 weeks Fzt:DU 29 weeks
body weight (g) 64.663.6
a 70.961.1
a 35.461.1
b
muscle weight (M. quadriceps femoris (%) 1.560.1
a 1.560.1
a 1.260.1
b
total DNA (mg) 521.3656.5
a 577.3697.9
a 299.6648.9
b
total RNA (mg) 305.1631.0
a 370.16108.2
a 139.9645.8
b
total Protein (mg) 378.1646.7
a 519.3656.0
b 149.965.1
c
RNA/DNA (mg/mg) 0.660.1
a 0.760.2
a 0.660.3
a
protein/DNA (mg/mg) 0.760.1 1.260.3
* 0.660.1
protein/RNA (mg/mg) 1.360.2
a 2.260.8
a 1.660.4
a
normalized non-polysomal RNA fraction (NP) 0.7760.29
a 0.7360.33
a 0.6860.35
a
normalized polysomal RNA fraction (P) 0.5860.28
a 0.4360.19
a 0.6460.47
a
relative translational activity (P/NP) 0.6360.07
a 0.5860,10
a 0.6460.40
a
total translational activity (P/NP)*RNA 192622
a 213638
a 90656
b
a,b - different superscripts indicate significant differences (p,0.05);
*- significantly different if compared to 11-week DU6P or Fzt:DU, respectively as evaluated using the Wilcoxon-signed rank test.
Furthermore the non-polysomal and polysomal RNA fraction in M. quadriceps femoris of Fzt:DU (29 weeks) and DU6P (11 and 29 weeks) female mice (n=4) was
analysed.
doi:10.1371/journal.pone.0039711.t002
Figure 8. In mid-aged female DU6P mice inhibition of PTEN by
means of reduced PTEN expression and increased PTEN
phosphorylation correlates with higher levels of AKT phos-
phorylation at Ser-473, inactivation of GSK3ß on one hand and
higher levels of S6K on the other. An increase of muscle mass is
due to higher levels of muscle glycogen and an increased rate of
protein synthesis in female 29-week DU6P mice.
doi:10.1371/journal.pone.0039711.g008
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[66]. Notably, fiber numbers were identical in DU6P mice and
controls. Interestingly, if normalized for higher DNA content as an
estimate of active genomes, protein/DNA ratios were 2-fold
increased in 29-week female DU6P mice if compared to Fzt:DU
mice, in fact revealing higher rates of protein expression per
cellular unit present in muscle fibers from 29-week female DU6P
mice. We were able to demonstrate that DU6P mice have similar
ratios of free mRNA versus mRNA bound to polysomes if
compared to controls arguing against a higher initiation rate for
protein translation. However, the amount of mRNA transcripts
present in polysomes was much higher in 29-week female DU6P
mice if compared to controls. On the other hand, we were able to
exclude a reduction of protein breakdown as a mechanism of
higher protein abundance in DU6P mice.
Conclusions
As a summarizing scheme, Figure 8 depicts mechanisms
identified in 29-week female DU6P mice. First our results clearly
demonstrate that selection for high protein mass also selects for
high muscle glycogen. This effect can unambiguously be related to
the AKT/GSK3ß pathway. For the acute activation of this
pathway exclusively inactivation of PTEN, by means of protein
expression and protein phosphorylation, can be used in order to
explain specific activation of AKT at Ser-473 in 29-week female
DU6P mice. We furthermore emphasize that the control of muscle
mass seems to occur in an age-dependent fashion since PTEN is
affected specifically in mid-aged but not in pubertal or advanced
aged female mice. In addition, we were able to argue against acute
involvement of a number of known effectors of AKT including
serum IGF-I and IGF-II, IGF-I receptor activation, PDK1-,
mTOR-, myostatin- and ILK-expression in 29-week female DU6P
mice. Since the mechanism presented is established by a total of
138 rounds of phenotype selections, we have reason to include
a particular physiological relevance to PTEN levels if the accretion
and maintenance of muscle tissue in mid-aged female mice is
concerned.
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